Stock Research for NTRR


Featured Broker: Ally Invest

Get the due diligence for another stock.


NTRR Stock Chart & Research Data

The NTRR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NTRR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


NTRR Due diligence Resources & Stock Charts

The NTRR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NTRR Detailed Price Forecast - CNN Money CNN View NTRR Detailed Summary - Google Finance
Yahoo View NTRR Detailed Summary - Yahoo! Finance Zacks View NTRR Stock Research & Analysis -

Stock Analysis

TradeIdeas View NTRR Trends & Analysis - Trade-Ideas Barrons View NTRR Major Holders - Barrons
NASDAQ View NTRR Call Transcripts - NASDAQ Seeking View NTRR Breaking News & Analysis - Seeking Alpha
Spotlight View NTRR Annual Report - OTC Report View NTRR OTC Short Report -
TradeKing View NTRR Fundamentals - TradeKing Charts View NTRR SEC Filings - Bar Chart
WSJ View Historical Prices for NTRR - The WSJ Morningstar View Performance/Total Return for NTRR - Morningstar
MarketWatch View the Analyst Estimates for NTRR - MarketWatch CNBC View the Earnings History for NTRR - CNBC
StockMarketWatch View the NTRR Earnings - StockMarketWatch MacroAxis View NTRR Buy or Sell Recommendations - MacroAxis
Bullish View the NTRR Bullish Patterns - American Bulls Short Pains View NTRR Short Pain Metrics -

Social Media Mentions

StockTwits View NTRR Stock Mentions - StockTwits PennyStocks View NTRR Stock Mentions - PennyStockTweets
Twitter View NTRR Stock Mentions - Twitter Invest Hub View NTRR Investment Forum News - Investor Hub
Yahoo View NTRR Stock Mentions - Yahoo! Message Board Seeking Alpha View NTRR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for NTRR - Insider Cow View Insider Transactions for NTRR - Insider Cow
CNBC View NTRR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NTRR - OTC Markets
Yahoo View Insider Transactions for NTRR - Yahoo! Finance NASDAQ View Institutional Holdings for NTRR - NASDAQ

Stock Charts

FinViz View NTRR Stock Insight & Charts - StockCharts View NTRR Investment Charts -
BarChart View NTRR Stock Overview & Charts - BarChart Trading View View NTRR User Generated Charts - Trading View

Latest Financial News for NTRR

Neutra's VIVIS Excited to Release New Gummy!
Posted on Tuesday January 18, 2022

KATY, TX / ACCESSWIRE / January 18, 2022 / Neutra Corp. (OTC PINK:NTRR) continues plans for Phase-1 clinical trials regarding the effectiveness of two hemp-based cannabinoids (CBDa) in stopping COVID-19 infection.

Neutra Concludes Record-Breaking Year, Aims for Greater Success in 2022
Posted on Monday December 06, 2021

KATY, TX / ACCESSWIRE / December 6, 2021 / Neutra Corp. is ending 2021 on a celebratory note, announcing the past year was its most successful on record.

Neutra's Deity Wellness Reports "Booming Interest" in Sales after Texas Judge Issues Injunction Making Delta-8 Legal
Posted on Wednesday November 10, 2021

KATY, TX / ACCESSWIRE / November 10, 2021 / Now that a Texas judge's ruling in favor of Delta-8's legality has ended lingering uncertainty about the substance, Neutra Corp. (OTC PINK:NTRR) subsidiary Deity Wellness has resumed working towards securing and closing numerous sales opportunities that had been placed on hold.

Latest VIVIS LOI Potential First Step to Phase 1 Clinical Trial on Preventing COVID-19 Infections Using CBD
Posted on Tuesday September 14, 2021

KATY, TX / ACCESSWIRE / September 14, 2021 / Neutra Corp. subsidiary VIVIS has signed a groundbreaking letter of intent (LOI) with a Houston clinical research company that, if it comes to a successful conclusion, would lead to testing hemp-based cannabinoids to treat COVD-19.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.